Taken together, the above findings indicated that elevated levels of EDEM1 contribute to tumor progression and serve as an important indicator for poor prognosis in breast cancer patients, thus providing a potential therapeutic target for cancer prevention. This evidence concerns the gene EDEM1 and neoplasm.